Caspase activation has been extensively studied in the context of apoptosis. However, caspases also control other cellular functions, although the mechanisms regulating caspases in nonapoptotic contexts remain obscure. Drosophila IAP1 (DIAP1) is an endogenous caspase inhibitor that is crucial for regulating cell death during development. Here we describe Drosophila IKK-related kinase (DmIKK3) as a regulator of caspase activation in a nonapoptotic context. We show that DmIKK3 promotes degradation of DIAP1 through direct phosphorylation. Knockdown of DmIKK3 in the proneural clusters of the wing imaginal disc, in which nonapoptotic caspase activity is required for proper sensory organ precursor (SOP) development, stabilizes endogenous DIAP1 and affects Drosophila SOP development. Our results demonstrate that DmIKK3 is a determinant of DIAP1 protein levels and that it establishes the threshold of activity required for the execution of nonapoptotic caspase functions.
INTRODUCTION
Inhibitor of apoptosis proteins (IAPs), originally found in baculoviruses, are present in organisms from viruses to yeasts to humans. The IAP family is comprised of endogenous caspase inhibitors that play crucial roles in developmental cell death in Drosophila and in life/death decisions in mammalian cells in various cancers. In mammals, additional roles for IAPs have been proposed in a variety of cellular processes, including the control of cell division, and in a number of different signaling cascades, such as transforming growth factor b activation, c-Jun N-terminal kinase regulation, and nuclear factor kB (NF-kB) activation (reviewed in Vaux and Silke, 2005) . However, the role of mammalian IAPs in vivo is unclear because a loss-of-function experiment of one IAP, X-linked IAP (XIAP), showed no obvious physiological or histological defects, and the animals had normal life spans because of redundant functions of c-IAP1 and c-IAP2 (Harlin et al., 2001) .
During early development, Drosophila IAP 1 (DIAP1) is an essential protein whose depletion leads to massive cell death in the embryo and the subsequent death of the fly (Wang et al., 1999; Goyal et al., 2000; Rodriguez et al., 2002) . DIAP1 inhibits caspases through direct binding or degradation, as in the case of the initiator caspase DRONC (Wang et al., 1999; Wilson et al., 2002) . The stabilization of DRONC upon the degradation of DIAP1 promotes cell death. Despite the importance of DIAP1 in preventing cell death, the DIAP1 protein itself is unstable, with an in vivo half-life of approximately 30 min (Wilson et al., 2002; Yoo et al., 2002) , suggesting that quantitative control of the DIAP1 protein level might be required to regulate caspase activation.
In addition to the control of DIAP1 degradationmediated caspase activation during apoptosis, the importance of other regulatory mechanisms of caspase activation under nonapoptotic conditions is widely recognized. Caspase activity is required not only for cell death but also for various physiological functions, including sperm individualization (Arama et al., 2003; Huh et al., 2004) ; neural stem cell differentiation (Fernando et al., 2005) ; erythrocyte, keratinocyte, and lens differentiation; and T cell and B cell proliferation (reviewed in Schwerk and SchulzeOsthoff, 2003) . However, the caspase-activating mechanisms of nonapoptotic conditions are largely unknown.
Here, we identify a novel regulator of caspase activation that promotes DIAP1 phosphorylation and degradation, using a dominant-modifier screen in Drosophila. We reveal that Drosophila IKK-related kinase (DmIKK3), a homolog of the noncanonical members of IkB kinase family (IKK3/IKKi or NAK/T2K/TBK1) that regulate NF-kB activation or interferon regulatory factor (IRF) 3 and 7 activation in mammals, determines the level of DIAP1. Ectopic expression of DmIKK3 caused DIAP1 phosphorylation and degradation, resulting in cell death. The mammalian homolog of DmIKK3, NAK/T2K/TBK1, also degraded and phosphorylated mammalian XIAP. Knockdown of DmIKK3 in the proneural clusters of the wing imaginal disc, in which nonapoptotic caspase activity is required for proper sensory organ development, stabilized the endogenous DIAP1 and affected Drosophila sensory organ precursor (SOP) development. Our results demonstrate that DmIKK3 is a determinant of the DIAP1 protein level and that it provides the threshold of caspase activity required for the execution of nonapoptotic functions.
RESULTS

apoptoxin7 (APTX7) Is Identified as a Suppressor of Reaper, which Encodes a Predicted Drosophila Homolog of IKK-Related Kinase
Caspase-dependent cell death is regulated by the expression of proapoptotic proteins such as Reaper (Rpr) that promote DIAP1 degradation, leading to caspasedependent cell death (reviewed in Hay et al., 2004 ). Thus, we should gain insight into the physiological functions of DIAP1 by identifying regulators of DIAP1 inhibition using a Rpr-induced phenotype (GMR-RprS; Hay et al., 1995) . To identify the regulators of DIAP1, we performed a dominant-modifier screen for Rpr-induced eye ablation using a set of deficiency strains (Bloomington Drosophila Stock Center) that cover more than 70% of the Drosophila genome, as described previously (Kuranaga et al., 2002;  see also the Supplemental Experimental Procedures in the Supplemental Data available with this article online). Fifteen mutant lines were identified and named apoptoxin (APTX) for their putative proapoptotic function. We identified Df-APTX7, which has deletions uncovering 38A6-40A1, as a suppressor of Rpr ( Figures 1A-1C ). In the secondary screen using small deficiencies, we identified the overlapping suppressor region as 38C3-38F2. Next, we tested flies with known mutations in the 38C3-38F2 region (Berkeley Drosophila Genome Project) for their ability to improve the Rpr-induced small-eye phenotype. Three lines corresponding to APTX7 (APTX7
36
, APTX7 46 , and APTX7 66 ) improved the Rpr-induced phenotype ( Figure   1D ). Interestingly, the CG2615 gene in the same region was also identified as a candidate gene in our misexpression screen for cell-death executioners (endd 29; Kanuka et al., 2005a) ; therefore, we determined the cDNA sequence of CG2615 in each of the three APTX7 alleles. CG2615 shows similarity to the IKK-related kinase family (Berkeley Drosophila Genome Project) and is named DmIKK3 (also known as ik2) ( Figure 1F ) ( Figure 1F ). DmIKK3 most closely resembles the human NAK (also known as T2K or TBK1) and IKK3 (also known as IKKi) ( Figure 1F) ; BLAST searches of the fly genome failed to reveal a second IKK3-like gene, suggesting that DmIKK3 may perform all of the functions that the two IKK-related kinases have in mammals.
DmIKK3 Promotes DIAP1 Elimination and Cell Death Because DmIKK3 was a candidate component in the pathway of Rpr-induced cell death, it was possible that DmIKK3 might act as a proapoptotic protein. To investigate this possibility, we transfected Drosophila S2 cells with expression vectors for DmIKK3. DmIKK3 strongly induced cell death, like Rpr ( Figures 1G and 1H) . Moreover, the generation of DmIKK3-expressing transgenic flies showed that DmIKK3 was a cell-death inducer because its ectopic expression in the fly compound eye showed a severe eye-ablation phenotype, which was similar to the Rpr phenotype ( Figures 1I-1K ). To verify that the DmIKK3-induced small-eye phenotype was caused by cell death due to caspase activation, we first used the TUNEL assay and fluorescence resonance energy transfer (FRET) analysis to detect caspase activity in the eye discs. The overexpression of DmIKK3 driven by GMR-GAL4 increased the number of TUNEL-positive cells in the posterior region of the morphogenetic furrow of eye discs (Figures 2A and 2B) . To determine the caspase activity in vivo, we used SCAT3, a FRET indicator for caspase activity (Takemoto et al., 2003) . In the eye discs of SCAT3-expressing flies with the GMR-GAL4 driver, the coexpression of DmIKK3 caused caspase activation (FRET abolishment) (Figures 2C and 2D) . We also carefully observed the cell shape in the eye discs of DmIKK3-expressing flies and noticed that many cells formed apoptotic bodies in these discs ( Figure 2D ). We further verified that the DmIKK3-induced small-eye phenotype was caused by cell death due to caspase activation because coexpression of a dominant-negative form of DRONC (DRONC DN) partially improved the DmIKK3-induced eye-ablation phenotype (Figures 2E and 2F) . These data support the idea that DmIKK3's ectopic expression induced cell death via caspase activation in the Drosophila eye. The observation that the coexpression of a caspase inhibitor could not completely rescue the rough-eye phenotype of DmIKK3-expressing flies, unlike its effect in Rpr-expressing flies (data not shown), suggested that overexpressed DmIKK3 might cause developmental defects or stress in the eye discs in addition to cell death.
We considered the possibility that DmIKK3 affects the degradation of DIAP1 because the strength of the celldeath induction by DmIKK3 was similar to that of Rpr, which induces cell death by promoting DIAP1 degradation ( Figures 1G-1K ). In fact, the endogenous DIAP1 protein level was significantly decreased in the DmIKK3-expressing region, as indicated by anti-GFP staining (Figures 2A Figure 1 . DmIKK3 Induces Cell Death in Cells and Flies (A) Deficiency screening for Rpr-induced cell death (see Results and Supplemental Experimental Procedures) . Each deleted region is indicated by a black box (suppressor) or a white box (no effect). Each tested mutant is indicated by its name in red (suppressor) or black (no effect). and 2B). Since DIAP1 degradation is promoted by the RHG (Rpr, Hid, and Grim) proteins (Hays et al., 2002; Holley et al., 2002; Ryoo et al., 2002; Wing et al., 2002; Yoo et al., 2002) , it is possible that DmIKK3 induced the transcriptional upregulation of RHG mRNAs, resulting in DIAP1 degradation and cell death. We used an H99 clone that has a deletion uncovering the RHG genomic region to investigate the genetic interaction between DmIKK3 and the RHG. DmIKK3-induced cell death and DIAP1 reduction were not suppressed in H99 mutant clones of eye discs ( Figures 2G-2J ). Consistent with this result, the expression of DmIKK3 did not induce the upregulation of RHG mRNA in larval eye discs (data not shown). These results indicated that DmIKK3 could induce DIAP1 reduction and cell death independently of the RHG proteins. To verify that DmIKK3 regulates DIAP1 degradation, S2 cells were cotransfected with DIAP1 and DmIKK3. DmIKK3 expression induced the degradation of exogenous FLAGtagged DIAP1 protein in a dose-dependent manner ( Figure 3A ). DmIKK3 did not affect the expression level of FLAG-diap1 mRNA ( Figure S1 ). These results suggested that the DmIKK3-induced DIAP1 reduction was mediated by the posttranslational degradation of DIAP1. We then tested whether the DmIKK3-induced DIAP1 degradation was inhibited by treatment with the proteasome inhibitor lactacystin, and we confirmed that the DmIKK3-induced reduction in DIAP1 was prevented by the proteasome inhibitor in S2 cells ( Figure 3B ). This finding suggests that the DmIKK3-induced DIAP1 degradation was mediated by the proteasome pathway.
DmIKK3 Physically Binds DIAP1
Next, we checked whether physical binding occurs between endogenous DmIKK3 and DIAP1. We performed an immunoprecipitation experiment against the endogenous DmIKK3 protein using an anti-DmIKK3 monoclonal antibody. The specificity of this antibody was confirmed by immunoblotting to detect endogenous DmIKK3 protein in normal and DmIKK3 knockdown cells (see below). Our results indicated that physical binding occurs between endogenous DmIKK3 and endogenous DIAP1 in S2 cells ( Figure 3C ). When the S2 cells were treated with DmIKK3 dsRNA, endogenous DIAP1 protein was not immunoprecipitated by the DmIKK3 antibody ( Figure 3C ). To elucidate the function of the ubiquitin-like (Ubl) domain of DmIKK3, we tested the binding of a deletion mutant for this domain ( Figure 1F ). DmIKK3DUbl interacted weakly with DIAP1, whereas wild-type or kinase-dead mutants of DmIKK3 significantly bound to DIAP1 ( Figure 3E ). Consistent with the binding assay, DmIKK3DUbl did not cause cell death or DIAP1 degradation in S2 cells ( Figure 1G and Figure 3D ). We failed to detect the binding of purified DIAP1 and DmIKK3 by a GST pull-down assay in vitro, indicating that this physical binding may not be direct. It is likely that DmIKK3 phosphorylates DIAP1 in a protein complex in cells and that the Ubl domain of DmIKK3 is required for efficient formation of the DmIKK3/DIAP1 complex.
are UAS-SCAT3/UAS-LacZ; GMR-GAL4/+ (C) and UAS-SCAT3/UASDmIKK3;GMR-GAL4/+ (D). (E and F) DmIKK3-induced small-eye phenotype is mediated by caspase. Eye phenotypes of UAS-DmIKK3 weak /UAS-LacZ;GMR-GAL4/+ (E) and UAS-DmIKK3 weak /+;UAS-DRONC DN/ GMR-GAL4
Conserved Role of IKK-Related Kinase in Phosphorylating IAP Protein in Drosophila and Mammals
We investigated whether DIAP1 degradation might be regulated by DmIKK3-induced phosphorylation. Wildtype DmIKK3 was autophosphorylated and induced the phosphorylation of DIAP1 in S2 cells, whereas none of the four mutant DmIKK3s generated from the alleles DmIKK3
, or DmIKK3DUbl did so ( Figure 3F ). Moreover, the kinase-dead DmIKK3 mutants did not reduce DIAP1 levels or cause cell death in S2 cells ( Figure 1G and Figure 3D ), and they did not cause eye ablation in adult flies ( Figure 1L ).
We next investigated whether the human IKK-related kinase NAK could also elicit DIAP1 degradation. The expression of human NAK in S2 cells strongly induced cell death as well as DIAP1 degradation, whereas a kinasedead form of NAK, NAK K41M , did not (Figures 4A and 4B) . These data imply that DIAP1 degradation mechanisms are conserved between mammalian IKK-related kinase and DmIKK3. To investigate whether mammalian IAP could be phosphorylated by mammalian IKK-related kinase, we tested for XIAP phosphorylation and degradation by NAK. When 293T cells were cultured in media with 10% serum, we could observe a band shift but not the reduction of XIAP protein (data not shown). XIAP band shift was cancelled by phosphatase treatment (data not shown). We then performed the same experiments under low-serum conditions (1%), and found that NAK expression induced both a band shift of XIAP and the reduction of XIAP protein ( Figure 4C ). We also observed that NAK phosphorylated XIAP in vitro ( Figure 4D) , suggesting that the function of IKK-related kinase in the phosphorylation and degradation of IAP is conserved in both Drosophila and mammalian cells.
DmIKK3 Acts as a Regulator for Endogenous DIAP1 Turnover
We considered it likely that endogenous DmIKK3 could function to regulate endogenous DIAP1 protein turnover. The endogenous DIAP1 level increased when the endogenous DmIKK3 level was decreased in S2 cells by treatment with DmIKK3 dsRNA ( Figure 5A ). We also found that knockdown of DmIKK3 in S2 cells did not affect the diap1 mRNA level, as examined by semiquantitative RT-PCR ( Figure 5B ). Next, to examine whether DIAP1 turnover was regulated by DmIKK3 in S2 cells, we performed cycloheximide (CHX) chase experiments, as described in a previous paper (Wilson et al., 2002) . We confirmed that the endogenous DIAP1 had a half-life of about 30 min in S2 cells ( Figure 5C ). However, when DmIKK3 expression was reduced in S2 cells, DIAP1 protein turnover was significantly delayed after CHX treatment ( Figure 5C ). These data strongly support the idea that DmIKK3 regulates endogenous DIAP1 protein turnover.
DmIKK3
Regulates Caspase Activation through Regulation of DIAP1 Level without Affecting Developmental Cell Death Next, we examined DmIKK3's regulation of the endogenous DIAP1 level in vivo. Since homozygous DmIKK3 mutants were usually embryonically lethal and the escapers died before the second larval stage, and since MARCM (mosaic analysis with a repressible cell marker) was unsuccessful due to a very low efficiency of recombination, we used RNA interference (RNAi) to analyze the DmIKK3 loss-of-function phenotype in vivo. We generated transgenic animals bearing an inverted repeat (IR) fragment of the DmIKK3 cDNA in the pUAST vector (DmIKK3 IR). Overexpression of the DmIKK3 IR induced a reduction in the coexpressed DmIKK3 protein level in S2 cells and suppressed the DmIKK3-induced phenotype in fly eyes (data not shown). We then used DmIKK3 knockdown lines for a mosaic experiment (see Experimental Procedures). The subset of DmIKK3 knockdown cells, which were labeled with GFP, exhibited stronger DIAP1 signal in the wing discs than cells with normal DmIKK3 levels did ( Figures 6B and 6D ), indicating that DmIKK3 determines the endogenous level of DIAP1 protein. In contrast, expression of the control LacZ IR did not lead to any accumulation of DIAP1 protein in the wing disc ( Figures  6A and 6C) .
Considering that the function of DIAP1 is to inhibit caspase activation, it is possible that the physiological role of DmIKK3 is to control caspase activity and cell death via regulation of the DIAP1 protein level. We did not observe significant changes in embryonic cell death in homozygous or transheterozygous DmIKK3 mutants ( Figures  6G-6J) . However, since the maternal DmIKK3 contribution might affect the cell death in DmIKK3 mutants during the early embryonic stage, we performed TUNEL staining in the DmIKK3 knockdown wing discs, as described above (Figures 6A-6D) . A large amount of naturally occurring cell death is observed in the wing disc of third-instar larvae (Milan et al., 1997) , and this cell death was not suppressed in the clone ( Figure 6B ) or in the DmIKK3 knocked-down posterior region ( Figure 6D ). It is possible that, while celldeath stimuli such as Rpr, Hid, and Grim promote cell death through strong DIAP1 degradation, DmIKK3-mediated determination of the DIAP1 level through the regulation of DIAP1 turnover might not be a major mechanism regulating developmental cell death.
Caspase activity without cell death controls various physiological processes, including cell differentiation; Figure 3 . DmIKK3 Degrades DIAP1 via Physical Binding (A) DmIKK3 induces DIAP1 degradation. S2 cells were transfected with pUAST-myc-DmIKK3 (0, 50, 100 ng) and pUAST-FLAG-DIAP1 (200 ng) driven by pWAGAL4 (100 ng). pUAST-LacZ was added to adjust the total amount of expression plasmid to 400 ng/well. (B) DmIKK3-induced DIAP1 degradation is mediated by the proteasome system. Transfected S2 cells were incubated for 24 hr and then treated with heat shock to induce DmIKK3 expression. Five hours after heat shock, the cells were incubated in the presence or absence of lactacystin for 6 hr. The levels of exogenous FLAG-DIAP1 or DmIKK3 protein were detected using mouse anti-FLAG or rabbit anti-DmIKK3 antibody. (C) Endogenous DIAP1 and DmIKK3 proteins physically bind each other. After treatment with GFP or DmIKK3 dsRNA for 48 hr, cell lysates were immunoprecipitated with a monoclonal antibody against DmIKK3 and then immunoblotted with rabbit anti-DIAP1 antibody or rabbit anti-DmIKK3 polyclonal antibody. An anti-HA monoclonal antibody (12CA5, Roche) was used as a control IgG (indicated as ''Control''). (D) Kinase-mutated or DUbl DmIKK3 cannot induce DIAP1 degradation. S2 cells were transfected with each of four myc-tagged DmIKK3 mutant alleles (200 ng) and pUAST-FLAG-DIAP1 (200 ng) driven by pWAGAL4 (100 ng). (E) DmIKK3's Ubl domain is required for its efficient binding to the DIAP1 complex. LacZ (as a control), myc-tagged DmIKK3, or mutant myc-tagged DmIKK3 was coexpressed with FLAG-DIAP1 under the control of pWAGAL4. Each cell lysate was immunoprecipitated with anti-FLAG M2 affinity gel and immunoblotted with an anti-myc antibody or anti-FLAG polyclonal antibody. The presence of DmIKK3 and DmIKK3 mutants in the lysate was verified by immunoblotting. Because DmIKK3 degrades DIAP1 protein and causes cell death, we collected twice as many DmIKK3-expressing cells as control or other mutant DmIKK3-expressing cells in order to standardize the amount of DIAP1 proteins. The relative amounts of DmIKK3 combined with DIAP1 were standardized with immunoprecipitated DIAP1 as a control. The graph shows the ratio of (A) (the ratio of immunoprecipitated mycDmIKK3 to immunoprecipitated FLAG-DIAP1) to (B) (the ratio of total myc-DmIKK3 to immunoprecipitated FLAG-DIAP1). (F) DIAP1 phosphorylation by DmIKK3. The autophosphorylation of DmIKK3 and phosphorylated DIAP1 is indicated in the upper panel. FLAG-GFP, FLAG-DmIKK3, or a FLAG-DmIKK3 mutant was expressed in 293T cells and immunoprecipitated by anti-FLAG M2 affinity gel. The immunoprecipitated proteins were subjected to an in vitro kinase assay using recombinant His-DIAP1 protein and [g- however, the regulatory mechanisms of caspase activity in this context are largely unknown. With this in mind, we decided to examine the effects of DmIKK3 knockdown on caspase activity in the absence of cell-death stimuli. Generally, an anti-active caspase antibody is used to stain dying cells. However, it is very hard to detect low or mild levels of caspase activity in cells by this method. We tried to detect caspase activation using an anti-active caspase antibody in the wing discs, but its positive signals were few and scattered (data not shown). Therefore, to determine the caspase activity in vivo, we used the caspase indicator SCAT3. Interestingly, the FRET abolishment was weak in a broad area of the wild-type wing discs (Figure 6E ), suggesting that caspase was mildly activated in wing discs even in nonapoptotic cells. This mild activation of caspase was suppressed by DmIKK3 knockdown ( Figure 6F ). Endogenous DEVDase activity was also detected in S2 cells and was suppressed when endogenous DIAP1 accumulated following treatment with DmIKK3 dsRNA ( Figure 6K ). These results imply that DmIKK3 controls endogenous caspase activity via quantitative regulation of the DIAP1 protein and that this mechanism might be involved in the regulation of nonapoptotic caspase functions.
DmIKK3 Is Involved in Macrochaete Formation through Control of Caspase Activation
Recently, we found that the number of macrochaetae forming in the scutellum of the notum is determined through a nonapoptotic function of caspases (Kanuka et al., 2005b) . Thus, we examined whether DmIKK3 controls SOP cell development and the formation of macrochaetae in vivo using DmIKK3 IR transgenic flies. The knockdown of DmIKK3 in the scutellum using the scabrous-GAL4 (Sca-GAL4) driver resulted in the appearance of extra macrochaetae ( Figures 7A and 7B ). Two sets of Senseless-positive SOP cells were detected in a control wing disc ( Figure 7C) ; however, we detected extra SOP cells in wing discs expressing diap1 or DmIKK3 IR ( Figures  7D and 7E ). These observations suggest that DmIKK3 may affect the caspase activity in proneural clusters to determine the correct number of SOP cells.
We then determined the caspase activity in the proneural clusters of flies expressing SCAT3 under the Sca-GAL4 driver. In the absence of cell-death stimuli, endogenous caspase activity was detected in the scabrous-expressing proneural clusters in wild-type wing discs ( Figure 7F) ; however, the expression of DIAP1 ( Figure 7G ) or the dominant-negative form of DRONC (B) Knockdown of DmIKK3 does not affect the expression of diap1 mRNA in S2 cells. S2 cells were treated with DmIKK3 dsRNA for 48 hr. GFP dsRNA was used as a control dsRNA. Forty-eight hours after dsRNA treatment, the total RNA was prepared for RT-PCR to measure the diap1 mRNA level. GAPDH was used as an internal control mRNA. (C) DIAP1 turnover is regulated by DmIKK3 in S2 cells. Cells were treated with GFP or DmIKK3 dsRNA for 48 hr, and CHX was then added to the medium for each period of time indicated. The expression levels of endogenous DIAP1 protein were detected in whole-cell lysates by immunoblotting using an anti-DIAP1 antibody. (Kanuka et al., 2005b) suppressed the caspase activity. Similarly, the knockdown of DmIKK3 also effectively suppressed caspase activity in the scabrous-expressing proneural clusters of the wing discs ( Figure 7H ). Thus, DmIKK3 appears to determine the number of macrochaetae through the regulation of caspase activity in a nonapoptotic fashion.
DISCUSSION
Quantitative Control of DIAP1 Regulates Caspase Activity in Nonapoptotic Functions
The work reported here identifies Drosophila IKK-related kinase as a regulator of DIAP1 turnover and demonstrates a physiological function for DIAP1, the control of SOP cell 
+;AyGAL4 UAS-GFP/UAS-LacZ IR (A), hs-Flp/+;AyGAL4 UAS-GFP/UAS-DmIKK3 IR (B), en-GAL4 UAS-SCAT3/UAS-LacZ IR (C), and en-GAL4 UAS-SCAT3/UAS-DmIKK3 IR (D).
(E and F) Reduction of caspase activity in the DmIKK3 knockdown cells in the posterior region of wing discs. Wing discs from third-instar larvae were examined by in situ confocal imaging for caspase activity using the FRET-based probe SCAT3. The ratio images of SCAT3-expressing cells are shown in (E) and (F). Note that the activation of caspases was observed in the wing discs (E) and the ratio level was increased by the coexpression of DmIKK3
IR (F). The genotypes shown are en-GAL4 UAS-SCAT3/UAS-LacZ IR (E) and en-GAL4 UAS-SCAT3/UAS-DmIKK3 IR (F). (G-J) Apoptosis occurs normally in embryonic homozygous or transheterozygous DmIKK3 mutants. Shown are
G250D (I), and DmIKK3
G19R
/DmIKK3 G250D (J) embryos double labeled for TUNEL (Gb-Jb and Gc-Jc, white) and b-gal (Ga-Ja, red) at stage 14-15.
(K) Knockdown of DmIKK3 reduces endogenous caspase activation in S2 cells. S2 cells were treated with DmIKK3 dsRNA for 48 hr. GFP dsRNA was used as a control dsRNA. Forty-eight hours after dsRNA treatment, the cell lysates were collected and assayed for caspase activity. Caspase activity (mean ± SD) was determined using the fluorescent substrate DEVD-MCA.
development, in a nonapoptotic role through the control of caspase activation. Roles of caspases in nonapoptotic situations have been studied in mammals (reviewed in Schwerk and Schulze-Osthoff, 2003) . Recently, some groups have reported that caspases and caspase regulators, likely acting at distinct points in time and space, are required for nonapoptotic processes in Drosophila. Arama et al. (2003) and Huh et al. (2004) demonstrated that caspases are required for spermatid individualization, the process in which haploid syncytial spermatids are differentiated into individual motile sperm. Inhibition of the GTPase Rac induces a defect in border-cell migration in the Drosophila ovary, and this defect is suppressed by the coexpression of DIAP1 or the reduction of caspase activity (Geisbrecht and Montell, 2004) . Furthermore, the nonapoptotic caspase activation must clearly be tightly regulated to prevent cells from dying inappropriately through apoptosis. It seems likely that DmIKK3 controls the quantity of DIAP1 in some cells, such as proneural clusters, thereby determining the level of caspase activity, which is required for some nonapoptotic processes. DmIKK3 also regulates the actin cytoskeleton through the DIAP1/caspase pathway (Oshima et al., 2006) . Interestingly, we also demonstrated that the mammalian IKKrelated kinase NAK can phosphorylate XIAP. The IKKrelated kinase can be activated in mammals in response to not only immune stimuli but also growth factors such as PDGF (Tojima et al., 2000) , suggesting that IKKrelated-kinase-mediated IAP regulatory functions might be involved in the immune system, as well as in development, through caspase activity that is required for nonapoptotic processes.
DmIKK3 as a Regulator of DIAP1 Degradation
Here, we demonstrated that DmIKK3 accelerated DIAP1 degradation in a kinase-dependent manner. This suggests that the DmIKK3-induced phosphorylation of DIAP1 is required to turn on the destruction switch and activate physiological phenomena that are normally inhibited by DIAP1. Different mechanisms of DIAP1 regulation have been proposed, including the promotion of the autoubiquitination of DIAP1 by RHG proteins (Hays et al., 2002; Holley et al., 2002; Ryoo et al., 2002; Wing et al., 2002; Yoo et al., 2002) , the N-end rule (Ditzel et al., 2003) , phosphorylation (Harvey et al., 2003; Pantalacci et al., 2003) , and transcription (Wu et al., 2003; Udan et al., 2003) . We demonstrated that the RHG proteins are not required for DmIKK3-induced DIAP1 degradation ( Figures 2G and 2I) . Regarding the N-end rule, we performed a CHX chase experiment using DRONC dsRNA in S2 cells and confirmed that the N-end rule pathway positively regulates endogenous DIAP1 turnover in S2 cells (data not shown). Hippo (Hpo) is a serine/threonine kinase belonging to the Ste20-like family of kinases that has been implicated in DIAP1 inhibition. Two different mechanisms of DIAP1 inhibition by Hpo have been proposed, one transcriptional and the other posttranslational. We therefore tested whether the Hpo-induced phosphorylation of DIAP1 is involved in the degradation of DIAP1 that is induced by Rpr or DmIKK3. When DIAP1 was mutated at the site where Hpo is predicted to phosphorylate (Ser159, Ser164, Thr114, or Thr115), it did not provide resistance against Rpr-or DmIKK3-induced degradation (data not shown), suggesting that the direct phosphorylation of DIAP1 by Hpo was not involved in DIAP1 degradation under our experimental conditions. A recent report provides evidence that Hpo regulates the transcription of DIAP1 rather than directly phosphorylating it (Huang et al., 2005) . We also show here that the knockdown of DmIKK3 in S2 cells caused the accumulation of endogenous DIAP1 (Figure 5A ) but did not affect the diap1 mRNA level ( Figure 5B ). Taken together, these findings indicate that DmIKK3 is a bona fide kinase that can regulate DIAP1 degradation via phosphorylation.
IAP Phosphorylation by IKK-Related Kinase in the Immune System
It is well accepted that two nonclassical IKKs, IKK-related kinases, are essential components of the innate immune response and not of the apoptotic signal. IRF-3, a transcriptional activator of interferon-b (IFN-b) , is a physiological target of IKK-related kinases in the mammalian response against bacteria and viral invasion (reviewed in Kawai and Akira, 2006) . NAK/T2K/TBK1 and IKK3/IKKi can also phosphorylate IRF-7, another family member that is required for the production of IFN-a. These reports demonstrated that IKK-related kinases are important for the immune response in mammals. MAVS (also called VISA, IPS-1, or Cardif) was recently identified as a downstream component of a virus-derived dsRNA sensor, RIG-I, that mediates the IRF-3 activation pathway (reviewed in Kawai and Akira, 2006) . MAVS binds TRAF6, an XIAP binding protein (Sanna et al., 2002) ; therefore, IKK-related kinases may participate in the modulation of this pathway through XIAP phosphorylation. The elucidation of IKK's mechanisms of action, including the modulation of IAP and caspase activity in nonapoptotic events, may thus improve our understanding of a variety of important physiological processes. Our results also point to the evolutionary correlation of caspase and immune activation.
EXPERIMENTAL PROCEDURES
Plasmid Construction
The expressed sequence tag (EST) clone GM07508 was purchased from Invitrogen as full-length DmIKK3 cDNAs. After confirming the sequences, the DmIKK3 fragment was inserted into the pUAST vector (pUAST-DmIKK3). We also subjected the cDNAs to PCR-based tagging with the short sequence encoding the Myc and FLAG epitopes, and the resulting fragments, myc-DmIKK3 and FLAG-DmIKK3, were inserted into the pUAST vector (pUAST-myc-DmIKK3), pCaspeR-hs vector (pCaspeR-hs-DmIKK3), and pcDNA3 vector (pcDNA3-FLAGDmIKK3). To create the kinase-dead mutants of DmIKK3 and the DmIKK3DUbl mutant expression vector, Gly19 was replaced with Arg, Asp160 was replaced with Asn, Gly250 was replaced with Asp, and the Ubl domain was deleted by the PCR-based introduction of a point mutation (Yanagawa et al., 1997 ) (pUAST-myc-DmIKK3
, and pcDNA3-FLAG-DmIKK3DUbl). The myctagged human NAK and kinase-dead NAK (pcDNA3-FLAG-NAK and pcDNA3-FLAG-NAK K41M ; Tojima et al., 2000) were used to construct pUAST-myc-NAK and pUAST-myc-NAK K41M . For the RNA interference (RNAi) experiment, a fragment containing the first 500 bp of the DmIKK3 ORF was inserted into pUAST-D13 (a gift from Dr. R. Ueda) as previously described (Leulier et al., 2002 ) (pUAST-DmIKK3 IR). The driver plasmids that express GAL4 under the control of the actin5C promoter-pWAGAL4 (a gift from Dr. Y. Hiromi); pUAST-LacZ (Igaki et al., 2000) ; pUAST-SCAT3 (Kanuka et al., 2005b) ; pcDNA3-FLAG-XIAP (Suzuki et al., 2001); and pcDNA3-FLAG-GFP, pCaspeRhs-Reaper, pCaspeR-hs-LacZ, pUAST-FLAG-DIAP1 , and pUAST-GFP (Kuranaga et al., 2002 )-were described previously.
Recombinant Proteins and Anti-DIAP1 Antibody
The N-terminally His 6 -tagged recombinant DIAP1 protein (His-DIAP1) was produced in E. coli strain BL21(DE3)pLysS (Novagen) using pRSET-His 6 -DIAP1 by incubating the bacteria with 0.1 mM isopropyl-1-thio-b-D-galactopyranoside (IPTG) for 20 hr at 18 C. The recombinant His-DIAP1 expressed in BL21 E. coli was purified on a Ni + column and then used to immunize rabbits (Hokudo Co.). The antiserum for DIAP1 was absorbed with extracts of BL21 E. coli to reduce the background.
RT-PCR
To detect diap1 and GAPDH mRNA expression, the total RNA was reverse transcribed, and PCR was performed using the diap1-specific primer set (5 0 -CCGGAATTCCACCATGGCATCTGTTGTAGCTGATCT-3 0 and 5 0 -CCGCTCGAGTCATTAAGAAAAATATACGCGCA-3 0 ). The primer sequences for the detection of GAPDH were previously described (Kanuka et al., 1999a) .
Fly Stocks, Generation of Transgenic Flies, and Clonal Analysis Flies were raised on standard Drosophila medium at 25 C, and transgenic strains were described previously (Kanuka et al., 1999b) . The following fly strains were used in this study: Df(3L)H99 FRT2A (Bello et al., 2003) ; UAS-DRONC DN (Quinn et al., 2000) ; UAS-Rpr (Zhou et al., 1997) ; Sca P309 -GAL4 (Reddy and Rodrigues, 1999) ) (Kozlova et al., 1998) ; GMR-RprS and UAS-DIAP1 (Hay et al., 1995) ; and UAS-LacZ IR (Kennerdell and Carthew, 2000) . Somatic clones were produced using the ey-Flp/+;;Df(3L)H99 FRT2A/Ubi-GFP FRT2A strain. To make mosaic animals with DmIKK3 knockdown cells, we used flip-out activation (Ito et al., 1997) to ectopically express DmIKK3 IR within limited groups of cells at various positions in larval tissues of the hs-Flp;AyGAL4 UAS-GFP line. Briefly, DmIKK3 knockdown clones were produced by heat-shock treatment at 37 C in an incubator for 60 min 3-4 days after egg laying and were identified as GFP-positive cells.
Histology, Immunohistochemistry, TUNEL, and FRET Assay TUNEL labeling and immunohistochemistry of the tissues were carried out as described (Kanuka et al., 2005b) . All fluorescently labeled samples were examined with a LSM5 confocal microscope (Carl Zeiss) for imaginal discs and a LEICA DM5000 B (Leica) for embryos. All light microscopy images were examined with a LEICA MZ16 F (Leica) for adult eyes and adult nota. The following antibodies were used for immunostaining in this study: rabbit anti-DIAP1 (1:2000, described above), mouse anti-GFP (1:200, Roche), mouse anti-b-gal (1:200, Promega), guinea pig anti-Senseless (1:500, a gift from Dr. H. Bellen; Nolo et al., 2000) , donkey anti-mouse IgG-Cy5 (1:100, Jackson), donkey anti-mouse IgG-FITC (1:100, Jackson), donkey anti-guinea pig IgGCy3 (1:100, Jackson), Cy3-conjugated streptavidin (1:100, Jackson), and donkey anti-rabbit IgG-Cy5 (1:100, Jackson). The confocal imaging analysis of FRET-based caspase activation was performed based on our previous report (Takemoto et al., 2003; Kanuka et al., 2005b) .
Cell Culture, Transfections, Cell-Death Assay, Immunoblotting, Caspase Activity Assay, and RNAi Experiments Drosophila S2 cell culture, cell-death assays, and immunoblotting were performed as described previously (Kuranaga et al., 2002 ; see also Supplemental Experimental Procedures). Immunoblotting of anti-b-tubulin antibody was used as a loading control. The relative amount of each protein was determined by densitometric analysis using Image Gauge software (Fujifilm). Quantitative data were obtained as a ratio of indicated protein signal to that of the loading control for each immunoblotting result in a ratio graph. Caspase activity assay, dsRNA synthesis, and dsRNA treatment were performed as described previously ; see also Supplemental Experimental Procedures).
Treatments with Proteasome Inhibitor and Cycloheximide
The proteasome inhibitor lactacystin (Calbiochem) was used. Briefly, S2 cells in a six-well plate were transiently transfected with 100 ng of pUAST-FLAG-DIAP1, 500 ng of pCaspeR-hs-DmIKK3, and 100 ng of the driver plasmid pWAGAL4. Twenty-four hours after transfection, the cells were subjected to heat shock (37 C for 30 min twice), and, after an additional 5 hr incubation, they were treated with 20 mM lactacystin for up to 6 hr. For cycloheximide (CHX) treatment, the cells were incubated at 27 C for 48 hr after dsRNA treatment, 50 mg/ml CHX was added, and the cells were further incubated for the times indicated.
Immunoprecipitation Analysis and Immunocomplex Kinase Assay
For the analysis of physical binding between expressed proteins, 5 3 10 6 S2 cells were plated on a 10 cm dish and transfected with 1 mg of pUAST-myc-DmIKK3, 1 mg of pUAST-myc-DmIKK3 mutants, or 1 mg of pUAST-LacZ and 500 ng of the driver plasmid pWAGAL4, with or without 2 mg of pUAST-FLAG-DIAP1. The transfected cells were lysed in lysis buffer as described previously (Nishitoh et al., 1998) . The cell lysates were incubated with 15 ml of anti-FLAG M2 affinity gel (Sigma) at 4 C overnight. To analyze the physical binding between endogenous proteins, 1 3 10 7 S2 cells were plated on a 10 cm dish, and the cells from ten dishes were collected and lysed with lysis buffer. The cell lysates were immunoprecipitated with a monoclonal antibody against DmIKK3 (S.H., unpublished data) using Protein A-Sepharose (Amersham). The immunoprecipitate was washed five times with lysis buffer. Following this, the samples were separated by SDS-PAGE, transferred to PVDF membranes, and analyzed by immunoblotting with the appropriate antibodies. The immunocomplex kinase assay has been described (Nishitoh et al., 1998 ; see also Supplemental Experimental Procedures).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and one figure and can be found with this article online at http:// www.cell.com/cgi/content/full/126/3/583/DC1/.
